Explore Biologics & Tides 2025: Unlocking Future Insights in Biologics Research & Development
Join leaders, experts and researchers at Biologics & Tides 2025, connecting pharmaceutical & biotech representatives as well as academia for high-level discussions on the latest innovations in biologics discovery & development. Biologics & Tides 2025 features the co-location of Proteins & Antibodies, Peptides, Oligonucleotides and Sustainability in Tides & Biologics
Proteins & Antibodies
Join leading scientific experts within Proteins & Antibodies, addressing critical strategies and the latest technological advancements in antibody engineering, bioanalytical techniques as well as the latest case studies in the development of next-generation biotherapeutics.
- New to 2025! Gain invaluable insights into novel strategies for cell line development & optimisation. Presentations will cover transposase mediated cell line generation, cell culturing techniques and advancing viral vector production through cell line development and engineering
- Gain a comprehensive understanding of downstream development for antibodies and Fc containing molecules. From Intensifying processes to improve productivity and reduce processing time, through to addressing protein aggregation challenges and single use technologies
- Discuss the latest novel tools & technologies for the display of biologics. Key opinion leaders will be presenting on addressing difficult targets with display technologies as well as developing novel in vitro display technologies for antibody discovery & engineering
- Take a deep dive into novel clinical development strategies through engaging presentations on selecting patient population, ADC clinical development, designing clinical trials to get the best proof of concept & insights into non-oncology indications
- Tap into the latest in ADC optimisation to enhance therapeutic potential through exciting sessions on linker / payload technologies, conjugation strategies and more
Agenda at a Glance
Day 1 | Track 1: Novel Tools & Technologies for the Display of Proteins & Antibodies
Day 1 | Track 2: ADC Design, Validation & Optimization to Enhance Their Therapeutic Potential
Day 1 | Track 3: Analytical Development: Stability & In-Depth Characterisation Methods for Proteins & Antibodies
Day 1 | Track 4: Novel Strategies for Cell Line Development & Expression Optimisation
Day 2 | Track 1: Antibody Discovery & Engineering
Day 2 | Track 2: New Formats: Cytokines & Immunocytokines
Day 2 | Track 3: Emerging Analytical Techniques, Developability & Quality Control Systems
Day 2 | Track 4: Downstream Development for Antibodies and Fc Containing Molecules
Day 3 | Track 1: AI/ML-Guided Protein & Antibody Engineering
Day 3 | Track 2: NextGen Multi-Specifics, Cell Engagers & Other New Modalities
Day 3 | Track 3: Novel Strategies for Clinical Development
Day 3 | Track 4: Novel Protein Process Development: Protein Purification & Recombinant Protein Production
Peptides
Peptides will bring together key experts in peptide chemistry and therapeutic development. With the latest technological advancements pushing the industry forward, join us in London to network, debate and discuss the pressing challenges & future opportunities.
- New to 2025! Discuss the latest innovations in peptide therapeutics analysis. Key opinion leaders will cover the latest advancements in mass spec methods such as de novo sequencing & quantitative proteomics; AI/ML for therapeutics analysis and peptide sequencing
- Stay at the forefront of peptide therapeutics research & development with hearing about novel targeted delivery methods, advances in peptide design and characterisation updates
- Discover the latest innovations in peptide chemistry including advanced computational methods and the implementation of AI/ML technologies
Agenda at a Glance
Day 1 | Track 5: Peptide Discovery
Day 2 | Track 5: Peptide Chemistry
Day 3 | Track 5: Peptide Therapeutics & Development
Oligonucleotides
Join key opinion leaders, bringing about a new era of innovation in this field. Presentations will be covering computational approaches, methods & tools to oligonucleotide CMC as well as analytical control strategies for oligos.
- New to 2025! Take a deep dive into oligo therapeutics analysis – from cell-based assay development through to improved computational methods, strategies & approaches including gene editors, CRISPR/CAS systems and guide RNA design
- Discuss the latest therapeutic development success stories with thought-leaders presenting on immunogenicity considerations, progress to clinical trials and RNA targeting
- Stay up-to-date with current advances in oligonucleotide delivery with presentations on nanoparticle technologies and conjugation strategies
Agenda at a Glance
Day 1 | Track 6: Oligo Discovery
Day 2 | Track 6: Oligo Chemistry & CMC
Day 3 | Track 6: Oligonucleotide Therapeutic Development & Optimisation
Sustainability in Tides & Biologics
Sustainability in Tides & Biologics addresses an important and expanding area, providing insights into driving sustainable innovation across biologics research & development; from sustainable synthesis approaches through to green manufacturing and sustainable supply chain processes.
- New to 2025! Immerse yourself in innovations pertaining to peptide & oligo green chemistry, manufacturing and sustainable supply chain development. Presentations will delve into sustainable engineering practices, advanced solvent recovery systems and ensuring supply chain continuity
- Express your thoughts on the future of solvent recovery systems and implementation of new sustainable manufacturing technologies, as well as taking a look at green manufacturing regulations
- Explore the latest methodology in sustainable drug formulations including the usage of green and renewable APIs
Agenda at a Glance
Day 1 | Track 7: Peptides & Oligo Green Chemistry
Day 2 | Track 7: Green Innovations in Peptide & Oligo Manufacturing
Day 3 | Track 7: Towards Sustainable Supply Chain Development & Commercialisation for Biologics
![ACROBiosystems Logo](https://oxfordglobal.com/hs-fs/hubfs/Sponsor%20Logos/ACROBiosystems-Logo.png?width=300&height=124&name=ACROBiosystems-Logo.png)
Biologics 2024 has been one of the best events I have attended so far in my career.
Territorial Sales Manager UK,
ACROBiosystems Co., Ltd.
![Genscript Logo](https://oxfordglobal.com/hs-fs/hubfs/Sponsor%20Logos/4709e03f-ed96-4606-80b6-4bdafa37794c-2-5668375logo-1.GenScriptCorporation_Logo_EN_Horizontal_FullColor.png?width=375&height=142&name=4709e03f-ed96-4606-80b6-4bdafa37794c-2-5668375logo-1.GenScriptCorporation_Logo_EN_Horizontal_FullColor.png)
The 1-2-1s are the best thing about Oxford Global events, well organised and good number of relevant contacts. Good high level contacts from big companies.
Advanced Therapies Specialist Team Leader,
Genscript
![Bioassay a Reaction Biology Company](https://oxfordglobal.com/hs-fs/hubfs/Sponsor%20Logos/Bioassay%20a%20Reaction%20Biology%20Company.png?width=300&height=100&name=Bioassay%20a%20Reaction%20Biology%20Company.png)
Impressed by the effort to bring people together.
Business Development Director,
Bioassay
![ImmunoPrecise](https://oxfordglobal.com/hs-fs/hubfs/Website/Logos/Sponsor%20Logos/ImmunoPrecise.png?width=225&height=177&name=ImmunoPrecise.png)
Nice set-up, with good support for exhibitors
Director of Client Relations,
ImmunoPrecise
Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of experiences
-
Experience over 120 dynamic interactive discussions, C-level debates, collaborative roundtables, and thought-provoking presentations & innovation showcases curated with insights from top industry leaders and experts to benchmark your research & development pipeline
-
Global Technological Showcase
An international & dynamic exhibition showcasing cutting-edge technologies and services from premier providers in the scientific field. -
Networking Emphasis
Unparalleled networking opportunities, including speed networking sessions, personalised 1-2-1 meetings, a vibrant drinks reception, and informal gatherings to foster meaningful connections. -
Innovative Poster Displays & Awards Ceremony
Inspiring poster displays and presentations unveiling the latest breakthroughs from emerging biotech, pharma, and start-up companies.
The 2025 programmes will delve into the entire value chain of bringing a biologics and tides-based drug onto the market. Proteins & Antibodies will take a deep dive into the the latest developments ranging from antibody discovery through to analytical & clinical development, new formats & nextgen therapeutics approaches. The co-located Peptides and Oligonucleotides programmes examine the discovery and innovative chemistry approaches for peptides and oligos as well as therapeutic development & optimisation. Via Sustainability in Tides & Biologics, key opinion leaders will address moving towards sustainable supply chain development & commercialisation for biologics. Furthermore, the events facilitate C-level panel discussions & roundtables pertaining to the latest biologics discovery & development case studies - ranging form the pivotal role of designing ADC drugs to enhance their therapeutic potential to novel strategies for upstream & downstream development.
Companies Represented Include
![adc therapeutics](https://oxfordglobal.com/hs-fs/hubfs/adc%20therapeutics.jpg?width=323&height=185&name=adc%20therapeutics.jpg)
![AstraZeneca](https://oxfordglobal.com/hs-fs/hubfs/Website/Logos/Attendee%20Companies/AstraZeneca.jpg?width=1181&height=286&name=AstraZeneca.jpg)
![bicycle therapeutics](https://oxfordglobal.com/hs-fs/hubfs/Website/Logos/Attendee%20Companies/bicycle%20therapeutics.jpg?width=576&height=267&name=bicycle%20therapeutics.jpg)
![Boehringer Ingelheim Logo](https://oxfordglobal.com/hs-fs/hubfs/Website/Logos/Attendee%20Companies/Boehringer%20Ingelheim%20Logo.png?width=1600&height=494&name=Boehringer%20Ingelheim%20Logo.png)
![crescendo-logo (1)](https://oxfordglobal.com/hs-fs/hubfs/Website/Logos/Attendee%20Companies/crescendo-logo%20(1).png?width=383&height=213&name=crescendo-logo%20(1).png)
![enara bio](https://oxfordglobal.com/hs-fs/hubfs/Website/Logos/Attendee%20Companies/enara%20bio.jpg?width=625&height=350&name=enara%20bio.jpg)
![GlaxoSmithKline](https://oxfordglobal.com/hs-fs/hubfs/Website/Logos/Attendee%20Companies/GlaxoSmithKline.png?width=1280&height=451&name=GlaxoSmithKline.png)
![Genentech](https://oxfordglobal.com/hs-fs/hubfs/Website/Logos/Attendee%20Companies/Genentech.png?width=600&height=160&name=Genentech.png)
![immunocore T cell](https://oxfordglobal.com/hs-fs/hubfs/Website/Logos/Attendee%20Companies/immunocore%20T%20cell.png?width=484&height=104&name=immunocore%20T%20cell.png)
![Novartis](https://oxfordglobal.com/hs-fs/hubfs/Website/Logos/Attendee%20Companies/Novartis.png?width=556&height=91&name=Novartis.png)
![Sanofi Wide](https://oxfordglobal.com/hs-fs/hubfs/Website/Logos/Attendee%20Companies/Sanofi%20Wide.png?width=800&height=400&name=Sanofi%20Wide.png)
![UCB](https://oxfordglobal.com/hs-fs/hubfs/Website/Logos/Attendee%20Companies/UCB.png?width=1200&height=1224&name=UCB.png)
Inspiring Tomorrow’s Breakthroughs: Unleashing Innovation & Collaboration in Biologics & Tides Research & Development
Join engaging presentations featured in our innovation and collaboration track running across the full event, inspiring growth and creating space for collaboration opportunities for all who attend. The core attendee mix includes early-stage and emerging biotech or (academic) spinoff companies developing their own platforms or technologies with fewer than 30 employees.
The Innovation & Collaboration track will be comprised of 10-minute presentations and focused panel discussion sessions, encouraging networking, facilitating collaborations & showcasing emerging innovations in biologics discovery & development.
Featuring Attendees from Biotech and/or (Academic) Spinoff Companies Interested In:
- Seeking collaboration partners with pharma and solution providers
- Discovering new investment opportunities with pharma
- Learning about the latest industry trends & challenges
- Keeping updated with new innovations and technology solutions
- Showcasing their company profile to a targeted and engaged audience
The Biologics & Tides Young Scientist Awards include the best poster presentation award and are intended to honour an outstanding individual performance for a scientific work by a PhD student, PostDoc or early career scientist.
Please submit your poster presentation by no later than 13th January 2025 in the below category:
- Protein/Antibody Engineering
- Bioanalysis & Characterisation
- Next Generation Biotherapeutics
- Peptides Chemistry & Therapeutics
- Oligonucleotides Chemistry & Therapeutics
- Sustainable Chemistry & Manufacturing
- Student (PhD), PostDoc or early career scientist under 35 years of age. Proof must be provided via an active student ID card or a copy of status
- Applicants must be the first AND presenting author of the submitted paper and register for the meeting by 13th January 2025
- ONLY ONE YSA submission per person will be accepted. If authors submit multiple abstracts for consideration for the YSA, only one abstract will be taken into consideration for the YSA
Applicants must follow the procedure as follows:
- Register and submit an abstract by 13th January 2025 using the registration link to the left on this page
- Once registered you will be provided with the online abstract submission form
- Prepare the poster or platform and present it (The poster presenter should be at the poster during all breaks.)
- The 3 winners with the highest scores will be announced at the Networking Drinks on the second day of the event
- The winners’ 10-minute oral presentations will take place during the networking drinks on day 2
The platform or poster presentation will be evaluated by senior scientists (consisting of our speaking and steering group committee for the Biologics series) on the basis of originality of the approach and quality of the work (e.g. appropriate methodology, interpretation of results, conclusiveness). All participants will receive the scoring and comments after the annual meeting via email.
The 3 winners receiving the highest scores will be announced at the Networking Drinks on the Day 2 and will be given a trophy as well as £1,000 contribution towards travel costs. Oxford Global will also provide winners with PLUS Pass – 12 months access to our content platform providing access to on-demand presentations, exclusive reports and highlights.
For further information contact help@oxfordglobal.com
Meet Our Expert Speakers
Biologics & Tides 2025 again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative, data and industry outlooks.
Below are some of our featured speakers:
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Darko-Skegro.jpg?length=600&name=Darko-Skegro.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Fernando-Albericio-scaled.jpg?length=600&name=Fernando-Albericio-scaled.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Screenshot%202024-04-12%20121536.png?length=600&name=Screenshot%202024-04-12%20121536.png)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Joel-Richard.jpg?length=600&name=Joel-Richard.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Kelly-Loyet.jpg?length=600&name=Kelly-Loyet.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Maja%20Firczuk.jpg?length=600&name=Maja%20Firczuk.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Screenshot%202024-06-06%20120242.png?length=600&name=Screenshot%202024-06-06%20120242.png)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Screenshot%202024-04-12%20121649.png?length=600&name=Screenshot%202024-04-12%20121649.png)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/926c3dba-7e4f-401f-bfee-7371b1eb5ae9-2-11764368speaker_photo-Michal_Shoshan_DSC5316_2.jpg?length=600&name=926c3dba-7e4f-401f-bfee-7371b1eb5ae9-2-11764368speaker_photo-Michal_Shoshan_DSC5316_2.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/1688206332082.jpg?length=600&name=1688206332082.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Simon-Krah.jpg?length=600&name=Simon-Krah.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Screenshot%202024-06-10%20144451.png?length=600&name=Screenshot%202024-06-10%20144451.png)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/1650581179296.jpg?length=600&name=1650581179296.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Screenshot%202024-04-11%20164609.png?length=600&name=Screenshot%202024-04-11%20164609.png)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Alastair-Lawson.jpg?length=600&name=Alastair-Lawson.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Alessandro%20Gori.jpg?length=600&name=Alessandro%20Gori.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Screenshot%202024-04-12%20081527.png?length=600&name=Screenshot%202024-04-12%20081527.png)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/5754e784-23d4-4060-931a-8c4c9a53f9de-2-11764368speaker_photo-Alvaro-centrado.jpg?length=600&name=5754e784-23d4-4060-931a-8c4c9a53f9de-2-11764368speaker_photo-Alvaro-centrado.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Screenshot%202024-05-20%20155248.png?length=600&name=Screenshot%202024-05-20%20155248.png)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Ana%20Pinho.jpg?length=600&name=Ana%20Pinho.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Screenshot%202024-04-12%20121447.png?length=600&name=Screenshot%202024-04-12%20121447.png)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Screenshot%202024-05-01%20134631.png?length=600&name=Screenshot%202024-05-01%20134631.png)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Andrew%20Buchanan.jpg?length=600&name=Andrew%20Buchanan.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Aneesh%20Karatt-Vellatt.jpg?length=600&name=Aneesh%20Karatt-Vellatt.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Anna%20Hine.webp?length=600&name=Anna%20Hine.webp)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Papini-Anna-Maria_2019_web-1.jpg?length=600&name=Papini-Anna-Maria_2019_web-1.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/1602666213879.jpg?length=600&name=1602666213879.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Bryce-Nelson.jpg?length=600&name=Bryce-Nelson.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Screenshot%202024-05-15%20135329.png?length=600&name=Screenshot%202024-05-15%20135329.png)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Christopher%20Hart.jpg?length=600&name=Christopher%20Hart.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Chris%20Coxon.jpg?length=600&name=Chris%20Coxon.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Chun%20Kong%20Mak.jpg?length=600&name=Chun%20Kong%20Mak.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/1620842052126.jpg?length=600&name=1620842052126.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/1655742566612.jpg?length=600&name=1655742566612.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/1578671144677.jpg?length=600&name=1578671144677.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Screenshot%202024-05-13%20133928.png?length=600&name=Screenshot%202024-05-13%20133928.png)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/David%20Evans.png?length=600&name=David%20Evans.png)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/David%20Brockwell.jpg?length=600&name=David%20Brockwell.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Ed%20Tate.jpg?length=600&name=Ed%20Tate.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/625aec81-3cad-4c10-a419-28479cf478f2-2-11764368speaker_photo-NWF21_06A5043-eef_dirksen-LR.jpg?length=600&name=625aec81-3cad-4c10-a419-28479cf478f2-2-11764368speaker_photo-NWF21_06A5043-eef_dirksen-LR.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Emma%20Grant.jpg?length=600&name=Emma%20Grant.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Logos/Attendee%20Companies/Mestag%20Therapeutics.png?length=600&name=Mestag%20Therapeutics.png)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Erik-Vernet-scaled.jpg?length=600&name=Erik-Vernet-scaled.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Screenshot%202024-06-07%20102109.png?length=600&name=Screenshot%202024-06-07%20102109.png)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Francisca%20Wollerton.jpg?length=600&name=Francisca%20Wollerton.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Georgios%20Skretas.jpg?length=600&name=Georgios%20Skretas.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/form-uploads/b5e0947d-6b9d-4388-ab18-db2e571020a7/b9fd84f4-18c2-4c8b-a236-941374c75c4f-2-11764368speaker_photo-Hagen-Cramer.jpg?length=600&name=b9fd84f4-18c2-4c8b-a236-941374c75c4f-2-11764368speaker_photo-Hagen-Cramer.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Screenshot%202024-05-09%20122453.png?length=600&name=Screenshot%202024-05-09%20122453.png)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/f7753da4-d5f8-4e70-a9a5-bbe2526a7377-2-11764368speaker_photo-Helen-Brightv2.jpg?length=600&name=f7753da4-d5f8-4e70-a9a5-bbe2526a7377-2-11764368speaker_photo-Helen-Brightv2.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/IANHAMLEY.jpg?length=600&name=IANHAMLEY.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/e3fcda17-f6ac-4f7a-8db7-381fdba5e27a-2-11764368speaker_photo-Ijeoma-H-S.jpg?length=600&name=e3fcda17-f6ac-4f7a-8db7-381fdba5e27a-2-11764368speaker_photo-Ijeoma-H-S.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Screenshot%202024-05-16%20135310.png?length=600&name=Screenshot%202024-05-16%20135310.png)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Immanuel-Lerner.jpg?length=600&name=Immanuel-Lerner.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/1713472332338.jpg?length=600&name=1713472332338.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Screenshot%202024-05-02%20150015.png?length=600&name=Screenshot%202024-05-02%20150015.png)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Jenny%20Fitting.jpg?length=600&name=Jenny%20Fitting.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Screenshot%202024-05-03%20155251.png?length=600&name=Screenshot%202024-05-03%20155251.png)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Screenshot%202024-04-12%20081026.png?length=600&name=Screenshot%202024-04-12%20081026.png)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Screenshot%202024-05-15%20135559.png?length=600&name=Screenshot%202024-05-15%20135559.png)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/1048e2c3-e8c7-4b49-9c34-abc9914eac2c-2-11764368speaker_photo-Jutta-Eichler-(2).jpg?length=600&name=1048e2c3-e8c7-4b49-9c34-abc9914eac2c-2-11764368speaker_photo-Jutta-Eichler-(2).jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/1673557783788.jpg?length=600&name=1673557783788.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Komal%20Kedia.jpg?length=600&name=Komal%20Kedia.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Laura%20Starkie.jpg?length=600&name=Laura%20Starkie.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Lauren%20Goodrich.jpg?length=600&name=Lauren%20Goodrich.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/1517422186895.jpg?length=600&name=1517422186895.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/1548016518801.jpg?length=600&name=1548016518801.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Screenshot%202024-04-24%20143019.png?length=600&name=Screenshot%202024-04-24%20143019.png)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Screenshot%202024-05-28%20150926.png?length=600&name=Screenshot%202024-05-28%20150926.png)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Screenshot%202024-05-13%20103735.png?length=600&name=Screenshot%202024-05-13%20103735.png)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/663fac50-0cec-4388-89b8-c0de04d4a721-2-11764368speaker_photo-Marc-Vendrell-photo-2018.jpg?length=600&name=663fac50-0cec-4388-89b8-c0de04d4a721-2-11764368speaker_photo-Marc-Vendrell-photo-2018.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Maria%20Fawaz.jpg?length=600&name=Maria%20Fawaz.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/1517783816238.jpg?length=600&name=1517783816238.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Screenshot%202024-05-20%20155446.png?length=600&name=Screenshot%202024-05-20%20155446.png)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/CELL/Cell%20Speaker%20Folder/Astrazeneca%20small%20logo.png?length=600&name=Astrazeneca%20small%20logo.png)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Mattias-Malm.jpg?length=600&name=Mattias-Malm.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Michael%20Dyson.jpg?length=600&name=Michael%20Dyson.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Michael%20Delaney.jpg?length=600&name=Michael%20Delaney.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Michelle%20Wantoch.jpg?length=600&name=Michelle%20Wantoch.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/CELL/Gene%20Speaker%20Photos/ucb.jpg?length=600&name=ucb.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Screenshot%202024-06-05%20133720.png?length=600&name=Screenshot%202024-06-05%20133720.png)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Screenshot%202024-04-30%20140101.png?length=600&name=Screenshot%202024-04-30%20140101.png)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Obinna%20Ubah.jpg?length=600&name=Obinna%20Ubah.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Screenshot%202024-04-12%20121952.png?length=600&name=Screenshot%202024-04-12%20121952.png)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Paul%20Reid.jpg?length=600&name=Paul%20Reid.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/1691425989237.jpg?length=600&name=1691425989237.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Screenshot%202024-05-13%20152118.png?length=600&name=Screenshot%202024-05-13%20152118.png)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Prasun%20Chakraborty.jpg?length=600&name=Prasun%20Chakraborty.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/1618039955520.jpg?length=600&name=1618039955520.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Screenshot%202024-04-29%20151708-1.png?length=600&name=Screenshot%202024-04-29%20151708-1.png)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Sarah%20Stuart.jpg?length=600&name=Sarah%20Stuart.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Sarah%20Hindson.jpg?length=600&name=Sarah%20Hindson.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Screenshot%202024-04-12%20081203.png?length=600&name=Screenshot%202024-04-12%20081203.png)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Screenshot%202024-05-23%20135021.png?length=600&name=Screenshot%202024-05-23%20135021.png)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Sophia%20Karagiannis.jpg?length=600&name=Sophia%20Karagiannis.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Screenshot%202024-05-24%20112708.png?length=600&name=Screenshot%202024-05-24%20112708.png)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Stefan-Zielonka-e1689255137578.jpg?length=600&name=Stefan-Zielonka-e1689255137578.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Screenshot%202024-04-11%20162912.png?length=600&name=Screenshot%202024-04-11%20162912.png)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/1517724579756.jpg?length=600&name=1517724579756.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Screenshot%202024-04-30%20155356.png?length=600&name=Screenshot%202024-04-30%20155356.png)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Logos/Attendee%20Companies/astrazeneca.jpg?length=600&name=astrazeneca.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Screenshot%202024-05-08%20152221.png?length=600&name=Screenshot%202024-05-08%20152221.png)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Tristan%20Vaughan.jpg?length=600&name=Tristan%20Vaughan.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Screenshot%202024-05-15%20140356.png?length=600&name=Screenshot%202024-05-15%20140356.png)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/06b7b7e3-37c5-41c8-aae2-14b59cde14bb-2-11764368speaker_photo-Vladimir_Gligorijevic.jpg?length=600&name=06b7b7e3-37c5-41c8-aae2-14b59cde14bb-2-11764368speaker_photo-Vladimir_Gligorijevic.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Walter%20Cabri.png?length=600&name=Walter%20Cabri.png)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Wen-Hsuan%20Chang.jpg?length=600&name=Wen-Hsuan%20Chang.jpg)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Screenshot%202024-04-12%20121155.png?length=600&name=Screenshot%202024-04-12%20121155.png)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/Screenshot%202024-04-11%20163218.png?length=600&name=Screenshot%202024-04-11%20163218.png)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Images/Speaker%20Photos/2bde6ab3-5a64-40d7-b886-1fda2c99ddcd-2-11764368speaker_photo-zr.jpg?length=600&name=2bde6ab3-5a64-40d7-b886-1fda2c99ddcd-2-11764368speaker_photo-zr.jpg)
Meet Our Esteemed Sponsors
Gold Sponsors
Silver Sponsors
Bronze Sponsors
Network & Programme Sponsors
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Sponsor%20Logos/a983d3c2-0d4c-4170-9135-e06896835693-2-5668375logo-EUR_Logo_horiz_color.png?length=600&name=a983d3c2-0d4c-4170-9135-e06896835693-2-5668375logo-EUR_Logo_horiz_color.png)
Interested in Sponsoring?
Oxford Global’s range of sponsorship opportunities are highly effective in enabling market immersion and visibility, with direct access to clients and potential customers.
Learn moreLatest Resources
![](https://oxfordglobal.com/hubfs/Website/Images/Resources/Biologics/FDA%20Fast%20Track%20ADC%20for%20Patients%20with%20Triple%20Negative%20Breast%20Cancer.jpg)
FDA Fast Track ADC for Patients with Triple Negative Breast Cancer
![](https://oxfordglobal.com/hubfs/Website/Images/Resources/Biologics/GSK%20Buys%20CureVacs%20mRNA%20Vaccine%20Business%20Providing%20Welcome%20Cash%20Injection.jpg)
GSK Buys CureVac's mRNA Vaccine Business Providing Welcome Cash Injection
![](https://oxfordglobal.com/hubfs/Website/Images/Resources/Biologics/Kurt%20W%C3%BCthrich%2c%20Using%20NMR%20to%20Determine%20the%203D%20Structure%20of%20Proteins.jpg)
2002 Nobel Prize for Chemistry: Kurt Wüthrich, Using NMR to Determine the 3D Structure of Proteins
![](https://oxfordglobal.com/hubfs/Website/Images/Resources/Biologics/Looking%20Back%20on%20the%202002%20Nobel%20Prize%20for%20Chemistry%20Mass%20Spectrometry%20for%20the%20Analysis%20of%20Proteins.jpg)
Looking Back on the 2002 Nobel Prize for Chemistry: Mass Spectrometry for the Analysis of Proteins
![](https://oxfordglobal.com/hubfs/Website/Images/Resources/Biologics/Antibodies%20Case%20Study%20Report%20Websize.jpg)
Accelerating Biologics Discovery & Development Through Transformative Technologies & Overcoming Strategic Challenges
![](https://oxfordglobal.com/hubfs/Website/Images/Resources/Biologics/Featured%20Image.jpg)
H5N1 Bird Flu Outbreaks: Effect on Vaccines
1 Shortlands,
Hammersmith International Ctre,
London, W6 8DR
Just minutes from three of London's main tube lines (Piccadilly, District and Hammersmith & City) and located in the heart of Hammersmith; Novotel London West is ideally located for trips to Westfield London, Harrods & Kensington High Street. Also conveniently located to Heathrow Airport with excellent road and rail links to the rest of the UK. This large and modern hotel offers on-site parking (chargeable), fitness suite and complimentary Wi-Fi throughout.
By Air
London Heathrow Airport - Novotel London West is accessible from Heathrow via the Underground on the Piccadilly Line - fares cost around £5 into Central London. A taxi from the airport will take approximately 20 minutes and will cost around £30 - £40.
London Gatwick Airport - The Gatwick Express runs every 15 mins - take it to Victoria station, and then get the District line to Hammersmith (about 15 mins). A taxi from the airport will take around 60 mins and cost between £65 - £80.
By Underground & Bus
Hammersmith Underground Station is adjacent to the hotel (3 minutes walk) with access to the Piccadilly, District and Hammersmith & City Lines. When exiting Hammersmith station, turn right and walk across the bus station. Cross over the roads using the island and keep on the right-hand side of Hammersmith Road. Continuing walking for 2 mins, and the hotel is accessible via stone steps.
For buses in central London, take route numbers 9 and 10. The main coach station (London Hammersmith) is 3 minutes walk away.
By Rail
The closest National Rail train station is Kensington Olympia (20 minutes walk).
By Car
Leave the A4 at the Hammersmith turning and proceed along Hammersmith Bridge Road to the large roundabout underneath the flyover. Take the fifth exit off the roundabout. Then turn left into Shortlands - the main hotel entrance and parking will be on your left-hand side.
Parking
Novotel London West offers over 240 on-site car parking spaces (charged per hour for residents parking). For further information including a map and full directions, please visit: www.novotel.com/gb/hotel-0737-novotel-london-west/index.shtml
We are closely monitoring the official guidance from health authorities, local governments, and the World Health Organization in order to support the health and well-being of our global community. The health and safety of our staff, customers and clients remains our number one priority.
As we continue to move forward with hosting our events in-person in 2024, we’ve added a series of Health & Safety guidelines and precautions in order to prepare for event safety. We carry out risk assessments for all our events to evaluate fundamental considerations and how to cover multiple risk scenarios.
Oxford Global has learned that third-party companies (recently EHotel Services, Business Travel Management/btravelmanagement and Exhibitors Hotel Reservations Services) are targeting conference attendees with a fraudulent hotel booking scheme.
Please note that none of these third-party companies are associated with Oxford Global in any way, nor have Oxford Global authorised them to use their names or trademarks on information they send out to attendees.
If you are contacted by a third-party company by phone or email using Oxford Global’s name or the name of Biologics & Tides 2025 and offering accommodation services, we urge exhibitors and attendees to proceed with extreme caution before signing anything sent by these companies or entering into any conversation or replying to any emails sent from these third-party companies.
Register Your Interest
Submit your details and a member of our team will be in touch